Cost Effectiveness Debate Now Features The Body Bag Argument
This article was originally published in The Pink Sheet Daily
Executive Summary
Center for Medicine in the Public Interest contends that over five years, 44,000 fewer patients will be alive if ICER's cost-effectiveness calculation for multiple myeloma treatments is adopted.